NCT00408902
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- Case Western Reserve University Cleveland, Ohio, United States
Clinical trial condition
Clear Cell Renal Cell Carcinoma
Explore clinical trials studying Clear Cell Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.
111 public trials
28 recruiting studies
Clear Cell Renal Cell Carcinoma trial results
NCT00499135
- Conditions
- Adenocarcinoma, Adult Solid Neoplasm, Carcinoma, +18 more
- Locations
-
- University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
NCT00335556
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +31 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of South Alabama Mobile, Alabama, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
NCT01141569
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- BCCA-Vancouver Cancer Centre Vancouver, British Columbia, Canada
- London Regional Cancer Program London, Ontario, Canada
- Ottawa Health Research Institute-General Division Ottawa, Ontario, Canada
- University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
Completed
Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA
NCT02607553
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- University of Texas Health Science Center, Houston Houston, Texas, United States
NCT00126594
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT01497821
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- Research Site Scottsdale, Arizona, United States
- Research Site St Louis, Missouri, United States
- Research Site Villejuif, France
- Research Site Heidelberg, Germany
Completed
Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer
NCT00324870
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- Peninsula Oncology and Hematology PA Salisbury, Maryland, United States
- University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
NCT00126503
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +19 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Dana-Farber Harvard Cancer Center Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- University of Pennsylvania/Abramson Cancer Center Philadelphia, Pennsylvania, United States
NCT02247583
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Katholieke Universiteit Leuven - Klinische Farmacologie en Farmacotherapie Leuven, Belgium